Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Scales to assess psychosis in Parkinson's disease: Critique and recommendations.

Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Abstract Text:

    hubert h fernandezHubert H Fernandez,dag aarslandDag Aarsland,gilles Gilles ,joseph h friedmanJoseph H Friedman,laura marshLaura Marsh,alexander i Alexander I ,werner poeweWerner Poewe,olivier rascolOlivier Rascol,cristina sampaioCristina Sampaio,glenn t stebbinsGlenn T Stebbins,christopher g goetzChristopher G Goetz,hubert h fernandezHubert H Fernandez,dag aarslandDag Aarsland,gilles Gilles ,joseph h friedmanJoseph H Friedman,laura marshLaura Marsh,alexander i Alexander I ,werner poeweWerner Poewe,olivier rascolOlivier Rascol,cristina sampaioCristina Sampaio,glenn t stebbinsGlenn T Stebbins,christopher g goetzChristopher G Goetz,

    Psychotic symptoms are a frequent occurrence in Parkinson's disease (PD), affecting up to 50% of patients. The Movement Disorder Society established a Task Force on Rating Scales in PD, and this critique applies to published, peer-reviewed rating psychosis scales used in PD psychosis studies. Twelve psychosis scales/questionnaires were reviewed. None of the reviewed scales adequately captured the entire phenomenology of PD psychosis. While the Task Force has labeled some scales as "recommended" or "suggested" based on the fulfilling-defined criteria, none of the current scales contained all the basic content, mechanistic and psychometric properties needed to capture PD psychotic phenomena and to measure clinical response over time. Different scales may be better for some settings versus others. Since one scale may not be able to serve all needs, a scale used to measure clinical response and change over time [such as the Clinical Global Impression Scale (CGIS)] may need to be combined with another scale better at cataloging specific features [such as the Neuropsychiatric Inventory (NPI) or Schedule for Assessment of Positive Symptoms (SAPS)]. At the present time, for clinical trials on PD psychosis assessing new treatments, the following are recommended primary outcome scales: NPI (for the cognitively impaired PD population or when a caregiver is required), SAPS, Positive and Negative Syndrome Scale (PANSS), or Brief Psychiatric Rating Scale (BPRS) (for the cognitively intact PD population or when the patient is the sole informant). The CGIS is suggested as a secondary outcome scale to measure change and response to treatment over time. (c) 2007 Movement Disorder Society.

    Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Publishing Authors By Initials

    hh fernandezHH Fernandez,d aarslandD Aarsland,g G ,jh friedmanJH Friedman,l marshL Marsh,ai AI ,w poeweW Poewe,o rascolO Rascol,c sampaioC Sampaio,gt stebbinsGT Stebbins,cg goetzCG Goetz,hh fernandezHH Fernandez,d aarslandD Aarsland,g G ,jh friedmanJH Friedman,l marshL Marsh,ai AI ,w poeweW Poewe,o rascolO Rascol,c sampaioC Sampaio,gt stebbinsGT Stebbins,cg goetzCG Goetz,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Movement disorders : official journal of the Movem

    VOLUME: 23

    Page Numbers: 484-500

    Journal Abbreviation:

    ISSN: 1531-8257

    DAY: 15

    MONTH: Mar

    YEAR: 2008

    Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8610688

    Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Scales to assess psychosis in Parkinson's disease: Critique and recommendations.

    AFFILIATION: Department of Neurology, McKnight Brain Institute/University of Florida, Gainesville, Florida, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Mov Disord

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Scales to assess psychosis in Parkinson's disease: Critique and recommendations Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News